KRISTY BESTGEN: Open Payments
NPI 1326487315 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 76 payments from 19 companies in 2025. Trend: 2023 $868 · 2024 $1,315 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $247 |
| Novo Nordisk Inc | 12 | $223 |
| ABBVIE INC. | 7 | $153 |
| PFIZER INC. | 8 | $147 |
| AstraZeneca Pharmaceuticals LP | 6 | $103 |
| SANOFI-AVENTIS U.S. LLC | 3 | $89 |
| Amgen Inc. | 4 | $67 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Esperion Therapeutics, Inc. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
Products named: MOUNJARO, Ozempic, QULIPTA, TZIELD, NURTEC ODT, NEXLETOL, VRAYLAR, GEMTESA.
Industry payments across MO — which companies pay providers there.
